You are here

Invega

On its annual list of price hike offenders, ICER calls out Bausch's Xifaxan, J&J's Invega

Fierce Pharma

Wed, 12/7/22 - 10:10 am

FDA approves new use for antipsychotic Invega

Yahoo/AP

Sat, 08/1/09 - 09:31 am

Janssen Pharmaceuticals

J&J asks FDA to broaden Invega use; Generics firms eye Shire's Fosrenol

Fierce Biotech

Mon, 02/9/09 - 10:39 am

Barr Laboratories